News

Suburban Propane Partners Reports Solid Q3 Financial Results

Suburban Propane Partners Reports Solid Q3 Financial Results

Suburban Propane Partners, L.P. Financial Overview

Suburban Propane Partners, L.P. (NYSE: SPH) has released its financial results, highlighting key figures for the third quarter of the fiscal year. The partnership reported a net loss of $14.8 million, or $0.23 per Common Unit, showcasing a slight improvement compared to last year’s net loss of $17.2 million, or $0.27 per Common Unit. During this quarter, the Adjusted EBITDA remained flat at approximately $27 million.

Impact of Seasonal Trends

In its seasonal business model, the partnership typically experiences a net loss in the third quarter. However, the leadership team has managed to achieve a solid performance despite fluctuating temperatures and commodity prices. President and CEO Michael A. Stivala remarked, “Our operations team has maintained its focus on safety while carefully managing costs and enhancing customer service.”

Strategic Financial Initiatives

During the quarter, Suburban Propane utilized excess cash flows and other proceeds to fund growth capital projects and reduce debt by $69 million, reflecting a proactive approach toward maintaining a stable financial foundation. With this funding, the partnership continues to support its operational initiatives, including enhancing its renewable natural gas operations.

Changes in Renewable Natural Gas Operations

The partnership experienced a minor reduction in average daily RNG injection compared to the previous year. Additionally, revenue from this segment experienced challenges due to lower pricing for environmental attributes mandated under the Renewable Fuel Standard. Despite this, Suburban Propane is committed to implementing operational improvements to boost RNG production and meet market demand.

Market Conditions and Customer Demand

In the third quarter, the retail propane gallons sold remained consistent at 71.9 million gallons, in line with last year’s performance. The average temperatures in the service areas were significantly warmer than normal, which can affect demand patterns.

Profit Margins and Revenue Analysis

Average propane prices rose by 4.7% compared to the prior year’s third quarter. The total gross margin for the quarter reached $160.6 million, remaining steady from the previous year. However, some adjustments for derivative instrument losses impacted the gross margin reported. The partnership’s strategic management of costs and pricing helped maintain this solid gross margin.

Operational Expenses and Administrative Management

The combined operating and general administrative expenses totaled $136.3 million, marking a slight increase of 0.5% from the prior year due to increased payroll and benefit-related costs, although offset by an insurance recovery gain. Both quarters included pension settlement charges, but these were excluded from Adjusted EBITDA calculations.

Dividend Announcement

On July 24, the partnership's Board of Supervisors approved a quarterly distribution of $0.325 per Common Unit for the three-month period ending June 28, which translates to an annualized distribution rate of $1.30 per unit.

Company Background

Established in 1928, Suburban Propane Partners, L.P. is a nationwide distributor of propane and related products, serving approximately 1 million customers across the United States. The company is well-regarded for its commitment to customer service, offering a diverse range of energy products, including renewable propane and natural gas.

Future Outlook

Suburban Propane’s commitment to maintaining financial strength and operational efficiency speaks to its long-term vision of sustainable growth. As the market evolves, the partnership aims to capitalize on its infrastructure and strategic initiatives while continuing to enhance its service capabilities.

Frequently Asked Questions

What are the third quarter results for Suburban Propane Partners?

Suburban Propane reported a net loss of $14.8 million, with revenues remaining consistent compared to the previous year.

How does the company manage its seasonal losses?

Suburban Propane utilizes strategies such as managing costs effectively and focusing on customer service to counteract seasonal losses in demand.

What initiatives does Suburban Propane have for its renewable natural gas operations?

The company is working on operational enhancements to increase RNG injection and advance capital projects related to renewable energy.

What is the company’s dividend distribution?

The partnership declared a quarterly distribution of $0.325 per Common Unit, translating to an annualized rate of $1.30.

What markets does Suburban Propane serve?

Suburban Propane operates nationwide, serving a diverse client base that includes residential, commercial, governmental, industrial, and agricultural customers.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

AIP Realty Trust Announces Successful Non-Brokered Offering

Updated Category News Views 177

AIP Realty Trust's Financial Milestone Achieved AIP Realty Trust has made waves in the investment community by successfully finalizing the initial tranche of a significant non-brokered private placement. These efforts have brought in an impressive total of 7,260,000 Preferred Units—Series B Convertible, valued at US$0.50 each, resulting in gross proceeds of...

Continue Reading
Medtronic's BrainSense™ Receives CE Marking for Parkinson's Care

Updated Category News Views 499

Medtronic’s Innovative Approval for Parkinson's Treatment Medtronic plc (NYSE: MDT), a global leader in healthcare technologies, has achieved a significant milestone by receiving CE Mark approval for its BrainSense™ Adaptive deep brain stimulation (aDBS) system and the BrainSense™ Electrode Identifier (EI). This remarkable advancement introduces the world's first...

Continue Reading
Understanding the New Rating for abrdn Asia-Pacific Income Fund

Updated Category News Views 84

KBRA's Rating Insights on abrdn Asia-Pacific Income Fund Recently, KBRA has taken significant steps by assigning a new rating to the Series B Mandatory Redeemable Preferred Shares (MRPS) of abrdn Asia-Pacific Income Fund, Inc. (NYSE: FAX). This rating stands at 'AA-', illustrating the organization's confidence in the stability and security of these investment instruments....

Continue Reading
Protect Your Investment: Join the Applied Therapeutics Class Action

Updated Category News Views 156

Understanding the Class Action for Applied Therapeutics Investors As an investor in Applied Therapeutics, Inc. (APLT), you may have felt the financial impact of recent challenges the company has encountered. The firm is currently facing a class action lawsuit aimed at addressing securities fraud that adversely affected investors between specific dates. This situation is...

Continue Reading
Heritage Capital Group Facilitates Mittauer's Strategic Sale

Updated Category News Views 205

Heritage Capital Group Facilitates Mittauer's Strategic Sale Heritage Capital Group, Inc. ("Heritage"), a respected investment banking and financial advisory firm known for serving middle-market and emerging growth companies, has successfully guided its client, Mittauer & Associates, Inc. ("Mittauer"), through a significant transition in its business landscape. This...

Continue Reading